1. Home
  2. ALTO vs DBVT Comparison

ALTO vs DBVT Comparison

Compare ALTO & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALTO
  • DBVT
  • Stock Information
  • Founded
  • ALTO 2003
  • DBVT 2002
  • Country
  • ALTO United States
  • DBVT France
  • Employees
  • ALTO N/A
  • DBVT N/A
  • Industry
  • ALTO Major Chemicals
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ALTO Industrials
  • DBVT Health Care
  • Exchange
  • ALTO Nasdaq
  • DBVT Nasdaq
  • Market Cap
  • ALTO 110.4M
  • DBVT 102.0M
  • IPO Year
  • ALTO N/A
  • DBVT N/A
  • Fundamental
  • Price
  • ALTO $1.85
  • DBVT $4.47
  • Analyst Decision
  • ALTO Strong Buy
  • DBVT Strong Buy
  • Analyst Count
  • ALTO 3
  • DBVT 2
  • Target Price
  • ALTO $5.00
  • DBVT $22.50
  • AVG Volume (30 Days)
  • ALTO 836.9K
  • DBVT 141.9K
  • Earning Date
  • ALTO 03-10-2025
  • DBVT 03-06-2025
  • Dividend Yield
  • ALTO N/A
  • DBVT N/A
  • EPS Growth
  • ALTO N/A
  • DBVT N/A
  • EPS
  • ALTO N/A
  • DBVT N/A
  • Revenue
  • ALTO $1,002,536,000.00
  • DBVT $12,515,000.00
  • Revenue This Year
  • ALTO N/A
  • DBVT N/A
  • Revenue Next Year
  • ALTO $7.36
  • DBVT $2,860.00
  • P/E Ratio
  • ALTO N/A
  • DBVT N/A
  • Revenue Growth
  • ALTO N/A
  • DBVT 125.54
  • 52 Week Low
  • ALTO $1.18
  • DBVT $0.44
  • 52 Week High
  • ALTO $2.40
  • DBVT $5.42
  • Technical
  • Relative Strength Index (RSI)
  • ALTO 64.64
  • DBVT 61.49
  • Support Level
  • ALTO $1.57
  • DBVT $4.30
  • Resistance Level
  • ALTO $1.93
  • DBVT $5.15
  • Average True Range (ATR)
  • ALTO 0.12
  • DBVT 0.41
  • MACD
  • ALTO 0.01
  • DBVT 0.06
  • Stochastic Oscillator
  • ALTO 80.00
  • DBVT 60.70

About ALTO Alto Ingredients Inc.

Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include major food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Other production. The Marketing and distribution segment participates in marketing and merchant trading for alcohols and essential ingredients; Pekin Campus produces and sells products produced at the company's Pekin, Illinois, campus, and about half of the firm's revenue flows from this segment. Other production makes and sells from the company's other production facilities.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

Share on Social Networks: